The concomitant presence of T2D and glucagon levels above normal, despite the absence of a typical glucagonoma syndrome triad, were the key for performing glucagon immunostaining in a clinically non-functioning pNET, without which the diagnosis of glucagon-producing NET would easily have been missed. This evidence concerns the gene GCG and type 2 diabetes mellitus.